To further elucidate the role of USP10/Notch1 signaling in CFs isolated from T2DM mice, CFs were treated with crenigacestat to inhibit Notch1 signaling while USP10 plasmids were employed to activate USP10. The gene discussed is USP10; the disease is type 2 diabetes mellitus.